132 related articles for article (PubMed ID: 32440846)
1. Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
Almaguer-Mederos LE; Aguilera-Rodríguez R; Almaguer-Gotay D; Hechavarría-Barzaga K; Álvarez-Sosa A; Chapman-Rodríguez Y; Silva-Ricardo Y; González-Zaldivar Y; Vázquez-Mojena Y; Cuello-Almarales D; Rodríguez-Estupiñán A
Cerebellum; 2020 Aug; 19(4):597-604. PubMed ID: 32440846
[TBL] [Abstract][Full Text] [Related]
2. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
3. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2.
Almaguer-Mederos LE; Almaguer-Gotay D; Aguilera-Rodríguez R; González-Zaldívar Y; Cuello-Almarales D; Laffita-Mesa J; Vázquez-Mojena Y; Zayas-Feria P; Rodríguez-Labrada R; Velázquez-Pérez L; MacLeod P
J Neurol Sci; 2017 Jan; 372():324-328. PubMed ID: 28017238
[TBL] [Abstract][Full Text] [Related]
4. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
[TBL] [Abstract][Full Text] [Related]
5. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
6. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients.
Almaguer-Mederos LE; Pérez-Ávila I; Aguilera-Rodríguez R; Velázquez-Garcés M; Almaguer-Gotay D; Hechavarría-Pupo R; Rodríguez-Estupiñán A; Auburger G
Mov Disord; 2021 Jun; 36(6):1372-1380. PubMed ID: 33548146
[TBL] [Abstract][Full Text] [Related]
8. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.
Monte TL; Reckziegel EDR; Augustin MC; Locks-Coelho LD; Santos ASP; Furtado GV; de Mattos EP; Pedroso JL; Barsottini OP; Vargas FR; Saraiva-Pereira ML; Camey SA; Leotti VB; Jardim LB;
Orphanet J Rare Dis; 2018 Jan; 13(1):20. PubMed ID: 29370806
[TBL] [Abstract][Full Text] [Related]
9. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
10. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
[TBL] [Abstract][Full Text] [Related]
11. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
13. Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 2.
Yang L; Shao YR; Li XY; Ma Y; Dong Y; Wu ZY
Neurology; 2021 Dec; 97(24):e2404-e2413. PubMed ID: 34706976
[TBL] [Abstract][Full Text] [Related]
14. Quantitative profiling and identification of plasma proteins of spinocerebellar ataxia type 2 patients.
Swarup V; Srivastava AK; Padma MV; Moganty RR
Neurodegener Dis; 2013; 12(4):199-206. PubMed ID: 23735416
[TBL] [Abstract][Full Text] [Related]
15. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
16. One‑carbon metabolism factor MTHFR variant is associated with saccade latency in Spinocerebellar Ataxia type 2.
Almaguer-Mederos LE; Jorge-Sainz Y; Almaguer-Gotay D; Aguilera-Rodríguez R; Rodríguez-Labrada R; Velázquez-Pérez L; González-Zaldívar Y; Cuello-Almarales D; Vázquez-Mojena Y; Canales-Ochoa N; Aguiar-Santiago J; Auburger G; MacLeod P
J Neurol Sci; 2020 Feb; 409():116586. PubMed ID: 31812845
[TBL] [Abstract][Full Text] [Related]
17. Specific linkages among luteinizing hormone, follicle-stimulating hormone, and testosterone release in the peripheral blood and human spermatic vein: evidence for both positive (feed-forward) and negative (feedback) within-axis regulation.
Foresta C; Bordon P; Rossato M; Mioni R; Veldhuis JD
J Clin Endocrinol Metab; 1997 Sep; 82(9):3040-6. PubMed ID: 9284740
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
19. Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2).
Zanatta A; Camargo CHF; Germiniani FMB; Raskin S; de Souza Crippa AC; Teive HAG
Cerebellum; 2019 Apr; 18(2):196-202. PubMed ID: 30264264
[TBL] [Abstract][Full Text] [Related]
20. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
